Pharmadrug Inc C.PHRX

Alternate Symbol(s): LMLLF

Medical Care Cannabis

PharmaDrug Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on the research, development and commercialization of controlled-substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural medicines. Sairiyo is engaged in the development of its patented reformulation of cepharanthine, a drug that has shown substantial third party validated potential for the treatment of infectious diseases and rare cancers. Sairiyo is also conducting research and development (R&D) in the psychedelics space for the treatment of non-neuropsychiatric conditions. The Company also operates through SecureDose Synthetics Inc., which is a pharmaceutical research and development company focused on the development of synthetic formulations of existing drugs for potential commercialization and distribution.

CSE:PHRX - Post by User

Pharmadrug Inc > Cohen bought remaining 20% of Pharmadrug at steep discount

<< Previous

Bullboard Posts

Next >>

Comment by SamRothsteinon Nov 10, 2021 1:21am

124 Views

Post# 34108213

RE:RE:Cohen bought remaining 20% of Pharmadrug at steep discount

Yes my posts are for people that actually follow the stock and the articles written about the stock, and are not written for paid bashers. Obviously I meant Cohen as a ceo had PHRX buy remaining shares of Pharmadrug. And of course you think it is worthless. You think whole company is worthless. But it is only your opinion that is worthless.